

Photo Credit: January 2025, Curacao, Brad Abernethy (Unfortunately, Brad reports some of the road dogs were hit by cars.)
Thank you for your support.
We have started taking action by contacting all those with vested interest in the creation of these critical Nonsurgical contraception products for dogs and cats: veterinary pharmaceutical companies, and additionally, animal care companies, veterinary research centers, humane societies, ministries of tourism, public health,etc. Here is the sample letter to be used/shared/modified as required. Please also feel free to use the letter should you wish to do so:
Investor Letter for Non-Surgical Pet Contraception Initiative
Subject: Pioneering a Sustainable Solution for Global Feral Animal Control
Dear [Recipient’s Name],
On behalf of our fellow petitioners, I want to commend [Company Name] for its commitment to advancing animal health in a sustainable and innovative way. Your mission statement—[Insert Mission Statement]—aligns closely with the concerns and values of thousands of dedicated pet owners, animal advocates, and global citizens who support an urgent and viable solution to the escalating crisis of feral animal overpopulation.
The Global Challenge & Untapped Opportunity
With an estimated 900 million stray dogs and cats worldwide, uncontrolled breeding contributes to significant public health concerns, including disease transmission, environmental damage, and overburdened shelters. Despite this, no major pharmaceutical company has yet taken the lead in developing a scalable, cost-effective, and non-surgical sterilization solution.
This presents [Company Name] with a unique opportunity to be a pioneer in veterinary innovation by developing the first non-invasive, affordable, and easily administered contraception solution for feral animals. Such a product would:
*Address a critical global issue while aligning with your corporate values.
*Open a new market for veterinary pharmaceuticals, with NGOs, municipalities, and pet organizations worldwide as key partners and customers.
*Enhance public perception and brand reputation through global recognition as a leader in ethical animal health solutions.
Strategic Partnerships & Market Potential
If successful products were developed and tested, major global organizations such as the United Nations, the American Veterinary Association, and other key NGOs would likely be interested in supporting, funding, and promoting its distribution. Additionally, international grants may be available to aid in research and development.
Why Now?
Our nonsurgical contraception products petition—signed by ........... supporters worldwide—demonstrates a strong public demand for a breakthrough in non-surgical pet contraception. We believe [Company Name] has the resources, vision, and innovation-driven culture to lead this transformative movement while generating a profitable and sustainable market solution.
Attached, you’ll find the petition, alongside information on leading research efforts in this field, including the upcoming 2nd Bacteriocin International Conference (BIC2025) in Brussels this May. This event will showcase cutting-edge developments in microbial science that could play a role in future contraceptive solutions.
We would be grateful if you could share this proposal with your research, marketing, and development teams who may be interested in exploring this endeavor further. Thank you for your time and for your dedication to advancing animal and human health. I look forward to the possibility of working together on this exciting and much-needed initiative.
Best regards,
[Add Name], [Add Location]
Attachments & Additional Resources:
Petition for Nonsurgical Pet Contraception: https://chng.it/PcxNgBCRGk
University Chile Nonsurgical Dog Contraception Research: https://www.egalitte.cl/
Egalitte: https:www.youtube.comwatchv=_iJv0rpzOoM&t=764s
Alliance for Contraception in Cat and Dogs: https://www.acc-d.org/
BIC2023 Bacteriocin International Conference: https://bic-2023.univ-lille.fr.
Promotional video for petition: https://youtu.be/44rlu0Vju_M